Effectiveness of the Combination of Everolimus and Tacrolimus With High Dosage of Mizoribine for Living Donor-Related Kidney Transplantation.

•The efficacy and safety of mizoribine therapy combined with everolimus was evaluated.•No significant difference in outcomes between therapy with and without everolimus was found.•The efficacy and safety of combination therapy with everolimus is confirmed in the short term.•There is hope for improving long-term outcomes with mizoribine combined with everolimus.